- Home
- CBFV vs BDTX Comparison
CBFV vs BDTX Comparison
Compare CBFV & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBFV | BDTX |
|---|---|---|
| Founded | 1901 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.9M | 148.1M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CBFV | BDTX |
|---|---|---|
| Price | $34.41 | $2.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $36.00 | $10.40 |
| AVG Volume (30 Days) | 4.0K | ★ 950.8K |
| Earning Date | 01-27-2026 | 03-05-2026 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.51 | 0.38 |
| Revenue | $40,244,000.00 | ★ $70,000,000.00 |
| Revenue This Year | $12.14 | N/A |
| Revenue Next Year | $13.09 | N/A |
| P/E Ratio | $68.79 | ★ $6.85 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.01 | $1.20 |
| 52 Week High | $37.45 | $4.94 |
Technical Indicators
Market Signals| Indicator | CBFV | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.02 | 44.81 |
| Support Level | $34.41 | $2.49 |
| Resistance Level | $36.45 | $2.70 |
| Average True Range (ATR) | 0.44 | 0.15 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 7.27 | 44.23 |
Price Performance
Historical ComparisonAbout CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.